Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001852075-25-000005
Filing Date
2025-10-03
Accepted
2025-10-03 16:27:30
Documents
1
Period of Report
2025-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1759523248.html 4  
1 FORM 4 wk-form4_1759523248.xml 4 3194
  Complete submission text file 0001852075-25-000005.txt   4780
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O LUX CAPITAL MANAGEMENT, LLC 1600 EL CAMINO REAL - SUITE 290 MENLO PARK CA 94025
Business Address
Dar Zavain (Reporting) CIK: 0001852075 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 251374293